The association of pre‐ and posthospital medication adherence in myocardial infarction patients
暂无分享,去创建一个
[1] K. Anstrom,et al. Hospital evaluation of health literacy and associated outcomes in patients after acute myocardial infarction , 2017, American heart journal.
[2] A. Colombo,et al. Should We Still Have Bare-Metal Stents Available in Our Catheterization Laboratory? , 2017, Journal of the American College of Cardiology.
[3] M. Mack,et al. Coronary Artery Bypass Graft Versus Percutaneous Coronary Intervention: Meds Matter Impact of Adherence to Medical Therapy on Comparative Outcomes , 2016, Circulation.
[4] Douglas S. Bell,et al. Potential benefit of electronic pharmacy claims data to prevent medication history errors and resultant inpatient order errors , 2016, J. Am. Medical Informatics Assoc..
[5] J. Ross,et al. Impact of Hospitalization for Acute Myocardial Infarction on Adherence to Statins Among Older Adults , 2016, Circulation. Cardiovascular quality and outcomes.
[6] C. Granger,et al. Health Information Technology: Meaningful Use and Next Steps to Improving Electronic Facilitation of Medication Adherence , 2016, JMIR medical informatics.
[7] T. Brennan,et al. Observing versus Predicting: Initial Patterns of Filling Predict Long-Term Adherence More Accurately Than High-Dimensional Modeling Techniques. , 2016, Health services research.
[8] T. Brennan,et al. Predicting adherence trajectory using initial patterns of medication filling. , 2015, The American journal of managed care.
[9] T. Henry,et al. Early Medication Nonadherence After Acute Myocardial Infarction: Insights into Actionable Opportunities from the TRANSLATE-ACS Study , 2015 .
[10] T. Henry,et al. Persistence with secondary prevention medications after acute myocardial infarction: Insights from the TRANSLATE-ACS study. , 2015, American heart journal.
[11] T. Henry,et al. Early Medication Nonadherence After Acute Myocardial Infarction: Insights into Actionable Opportunities From the TReatment with ADP receptor iNhibitorS: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) Study. , 2015, Circulation. Cardiovascular quality and outcomes.
[12] E. Peterson,et al. Persistence of evidence-based medication use after discharge from academic versus nonacademic hospitals among patients with non-ST-segment elevation myocardial infarction. , 2014, The American journal of cardiology.
[13] R. Haynes,et al. Interventions for enhancing medication adherence. , 2008, The Cochrane database of systematic reviews.
[14] T. Brennan,et al. Untangling the relationship between medication adherence and post-myocardial infarction outcomes: medication adherence and clinical outcomes. , 2014, American heart journal.
[15] Antonio Colombo,et al. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study , 2013, The Lancet.
[16] H. Quan,et al. Case definitions for acute myocardial infarction in administrative databases and their impact on in-hospital mortality rates. , 2013, Health services research.
[17] G. Stone,et al. Stent thrombosis after primary angioplasty for STEMI in relation to non-adherence to dual antiplatelet therapy over time: results of the HORIZONS-AMI trial. , 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[18] T. Brennan,et al. Comparative cost-effectiveness of interventions to improve medication adherence after myocardial infarction. , 2012, Health services research.
[19] D. Gustafson,et al. The roles of past behavior and health beliefs in predicting medication adherence to a statin regimen , 2012, Patient preference and adherence.
[20] M. Heisler,et al. Physician assessments of medication adherence and decisions to intensify medications for patients with uncontrolled blood pressure: still no better than a coin toss , 2012, BMC Health Services Research.
[21] T. Brennan,et al. Targeting cardiovascular medication adherence interventions. , 2012, Journal of the American Pharmacists Association : JAPhA.
[22] Lonny Reisman,et al. Full coverage for preventive medications after myocardial infarction. , 2011, The New England journal of medicine.
[23] Steven Baroletti,et al. Medication Adherence in Cardiovascular Disease , 2010, Circulation.
[24] P. Austin,et al. Patterns of use of thienopyridine therapy after percutaneous coronary interventions with drug-eluting stents and bare-metal stents. , 2009, American heart journal.
[25] R. F. Kelly,et al. Association of medical noncompliance and long-term adverse outcomes, after myocardial infarction in a minority and uninsured population. , 2009, Translational research : the journal of laboratory and clinical medicine.
[26] P Michael Ho,et al. Medication Adherence: Its Importance in Cardiovascular Outcomes , 2009, Circulation.
[27] Ping Li,et al. Prevalence, Predictors, and Outcomes of Primary Nonadherence After Acute Myocardial Infarction , 2008, Circulation.
[28] D. Alter,et al. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. , 2007, JAMA.
[29] K. Chan,et al. Methods for evaluation of medication adherence and persistence using automated databases , 2006, Pharmacoepidemiology and drug safety.
[30] M. Cheang,et al. Validity of a Prescription Claims Database to Estimate Medication Adherence in Older Persons , 2006, Medical care.
[31] H. Quan,et al. Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data , 2005, Medical care.
[32] B. Gage,et al. Accuracy of ICD-9-CM Codes for Identifying Cardiovascular and Stroke Risk Factors , 2005, Medical care.
[33] C. Rand,et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. , 1999, Medical care.
[34] A V Prochazka,et al. The assessment of refill compliance using pharmacy records: methods, validity, and applications. , 1997, Journal of clinical epidemiology.